home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  April 17, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries

The Research Cooperative

also "The Research Collective" a Nationalist Socialist Organization
POCO BC
Canada
Toll free: +011-604-941-9022

Phone: +011-604-945-8408
Fax: +011-604-941-9022

Description:

A Local Internet Services Company led by D. A. Flores (Owner/Principal) (PoCo BC Canada V3B 1G3).

Areas for Internet-Based Research at this time are: 

  • WWW Internet Franchised Content Provider. Hum-Molgen.org is a partner website.
  • Enrichment with Nutraceuticals for Dietetic Food Production. Propietary development of VitD2/D3 agonist drug lead candidate for protecting against and treatment in osteoporosis.
  • Investing in Industrial Agri-retailing in BC Canada. Aquaponics and salmonids rearing and hydroponics aquatic plant water hyacinth and marine seagrasses for ensilage and hay making for feeding of beef and dairy, hogs, poultry and fish feeding. Cropped pharma. "Green" materials for manufacturing and energy generation. 
  • Investing in Industrial Co-ops for Developing Countries including the Tropics for Cottage Industries, Small Farms, Microbusinesses (coventionally women-led) and Trades (Building industries).
  • Biofuel & Green Materials Manufacturing Mitigating GHG Emissions in the Long Term (reported for USD$100M funding slated).
  • Orthochem Laser Gel Documentation. We are now proposing with Carmot Therapeutics, Berkeley CA USA for future proteomics research and drug leads discovery with their proprietary T2DM research. Incretins and gut interventive drugs to avert the insulinemic condition against developing the type 2 diabetic milletus (T2DM) and resistance is "SkyeBlue's" own venture in the drug management area.
 
Plse contact/advise Us in case of any problems or issues pertaining to these.
We would be glad to share with such queries regards investment and opportunities.
 
Let us know by leaving your corroborative/collaborative intentions with Contact Info: Complete name, Email, Telephone no. and Mailing address (physical) where your party is reachable.
 
We would be glad to be able to know of you with Academic and/or Industrial Affaires.
 
Best,
 
D. A. Flores, BA (KZOO), MAPPLSC (UNSW)

OWNER/PRINCIPAL
SKYE BLUE INTERNET
POCO BC V3B 1G3
CANADA 
 
 

 
SKYEVIEW: What is trades cooperativity for the Philippine Islands of Asia? Let's awaken to the potential movement of industrialization through: agroindustrial farming & food, microbusiness activity with women for cottage industries, and agro-cropping for food, production and even for export Overseas.  
 
 
SKYEVIEW: Our corroborative/collaborative Internet-based research with other parties for 2022/23 we would like to share and highlight with you at The Research Cooperative (now also The Research Collective): -Internet (WWW) Franchised Content Provider. Hum-Molgen.org is a partnered website. -Enrichment with Nutraceuticals & Dietetic Food Productions. Proprietary development of VitD3 agonist drug lead candidate for protecting against and treatment in osteoporosis. -Investing in Industrial Agri-retailing in BC Canada. Aquaponics and salmonids rearing and hydroponics aquatic plant water hyacinth and marine seagrasses for ensilage and hay making for feeding of beef and dairy, hogs, poultry and fish feeding. Cropped pharma. Futuristic "Green" materials for manufacturing and energy generation. -Investing in Industrial Co-ops for Developing Countries including the Tropics for Cottage Industries, Small Farms, Microbusinesses (women-led) and Trades (Building industries). -Biofuel & Green Manufacturing to Mitigate Long-term GHG Emissions (as reported for USD$100M funding). -A Collaborative in Orthochemical Laser Gel Documentation. We are now collaborating with Carmot Therapeutics, Berkeley CA USA for future proteomics research and drug leads discovery with T2DM research. Incretins and gut interventive drugs to avert the insulinemic condition against developing the type 2 diabetic milletus (T2DM) and resistance is a possible area drug lead discovery.
 
(c) SKYE BLUE INTERNET. 2023-2050. PORT COQUITLAM, B. C.  V3B 1G3  CANADA. 


Selected Categories:
Product Company   Service Company
Consulting
- General
Contract
- Services
Professional
- Communications

Last update of this entry: July 03, 2023

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.